PlainPharmaWatch

CMS Open Payments · Program Year 2024

IZI Medical Products, LLC

IZI Medical Products, LLC reported $59,570.30 across General Payments, Research, and Ownership to 15 physicians and teaching hospitals across 15 transactions.

$59.6K Below-median payer
All-tracks total
15 Below-median volume
Transactions
15 Below-median reach
Recipients
+$5.9K
General Payments vs PY2023

IZI Medical Products, LLC reported $59,570.30 across all CMS Open Payments tracks (General + Research + Ownership) to 15 physicians and teaching hospitals in Program Year 2024 - ranking #1313 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $59,570.30, averaging $4.0K per recipient.

IZI Medical Products, LLC's payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

14/100

Total payments

F

11/100

Transaction volume

F

10/100

Physician reach

F

10/100

Payment type diversity

F

23/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer izi-medical-products-llc IZI Medical Products, LLC

$59.6K · #1313/1,925 · 0.0% industry · PY2024

  • TOT $59.6K
  • RANK #1313
  • SHARE 0.0%
  • TXN 15
  • RCP 15
  • CAT 2
  • GEN $59.6K
  • ΔGEN +$5.9K
  • TOP1 80.9%
  • PY 2024

Nearest volume peer: Natus Medical Incorporated ($59.5K)

IZI Medical Products, LLC (t…$59.6KNatus Medical Incorporated$59.5KKairos Surgical Inc$59.4KPharmaceutical Business Cons…$59.4KTrevena, Inc.$59.3K
All-tracks payment totals near IZI Medical Products, LLC (CMS Open Payments PY2024)

IZI Medical Products, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

IZI Medical Products, LLC's CMS-reported General Payments increased by $5.9K (+11.0%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: IZI MEDICAL PRODUCTS, LLCPY2023: IZI MEDICAL PRODUCTS, LLCPY2024: IZI Medical Products, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$53.7KPY2024$59.6K
PY2023
$53,686.09
PY2024
$59,570.30

What the Data Shows for IZI Medical Products, LLC

The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For IZI Medical Products, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.

Of the 2 general-payment categories charted below, "Royalty or License" is the largest at $57.6K across 3 transactions, 96.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Royalty or License" leads IZI Medical Products, LLC's 2-category general-payment breakdown at $57.6K, 96.7% of the reported total.

How IZI Medical Products, LLC divides its payments

Ranked by total dollars reported per category

1. Royalty or License$57.6K2. Food and Beverage$2.0K
Payment Type Amount Transactions
Royalty or License $57.6K 3
Food and Beverage $2.0K 12

Recipient Concentration in General Payments

The five largest recipient relationships account for $58,839.87 (98.8%) of $59,570.30 in this company's General Payments records across 9 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for IZI Medical Products, LLC

The five named recipients with the highest reported General Payments from this company

Douglas P Beall$48.2KDaniel B Kopans$9.7KPankaj Jain$377.42John Kresl$329.49Justin Famoso$280.43
  1. 1

    Douglas P Beall

    $48,171.53 across 3 reported transactions

  2. 2

    Daniel B Kopans

    $9,681.00 across 1 reported transactions

  3. 3

    Pankaj Jain

    $377.42 across 2 reported transactions

  4. 4

    John Kresl

    $329.49 across 2 reported transactions

  5. 5

    Justin Famoso

    $280.43 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

IZI Medical Products, LLC ranks #1313 of 1,925 by total payments (bottom 32% by spend) but is notably more concentrated than that alone would suggest -- #235 of 1,838 by HHI (top 13% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.

00.30.50.81.16579.96674.26768.56862.86957.1Total payments ($M)Concentration (HHI, 0-10,000)
IZI Medical Products, LLC (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as IZI Medical Products, LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about IZI Medical Products, LLC.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with IZI Medical Products, LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

IZI Medical Products, LLC ranks #1313 of 1,925 by all-tracks total payments, led by "Royalty or License".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download IZI Medical Products, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.